Midterm 2 - Notes 5 (Part 2) Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

What 3 signals help to regulate the cell cycle?

A
  1. GPCR
  2. Protein phosphatase
  3. Nucleotide exchange factor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What 2 ways can transport proteins?

A
  1. Peptide/drug transporter

2. Cadherin family protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What does the 2nd case study describe?

A

Whole genome cancer approach

- mutation evolution in a lobular breast tumour profiled at single nucleotide resolution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What type of tools did they use on metastatic tumours? (3)

A
  1. Whole genome sequencing
  2. Transcriptome sequencing
  3. Illumia sequencing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What was the control sample in the 2nd case study?

A

Blood sample from same patient

- provides reference genome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Why were the lengths made longer?

A

To make it easier to detect differences

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What could the tumour transcriptome not do?

A

Give coverage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What were the mutations likely caused by?

A

Somatic tumours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How can you tell if its a somatic mutation or not?

A

See if it was present in the reference genome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What indicates the expression level of a gene?

A

The number of genes that are counted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How can you tell if there is over/under expression in a gene?

A

Compare it to the reference genome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What can changes of expression be caused from?

A

Epigenetic change

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What did they use in the experimental design?

A

Used whole genome sequencing to look for differences and re-arrangements
- didnt use whole genome sequencing on the control

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What did they use for the control instead of whole genome sequencing?

A

Used a pipeline to identify candidate differences in protein coding genes and then went back to the target to use PCR and Sanger sequencing to see what the differences were

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What did they develop to detect alterations?

A

Algorithms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What were the alterations tested? (4)

A
  1. Insertions/deletions
  2. Inversions
  3. Gene fusions
  4. Copy number alterations
    - used FISH for this one
17
Q

What was the easiest thing to detect?

A

SNVs

18
Q

What did they remove from the SNVs? (2)

A
  1. Pseudogenes

2. HLA sequences

19
Q

When they re-sequenced, what did they use?

A

Sanger

20
Q

What were they surprised they found in the 2nd case study?

A

Finding 5 transcriptomes in the sequencing data

21
Q

Were somatic mutations identified?

A

Yes

22
Q

What did they want to identify?

A

If the mutation actually was present in a few cells in the primary tumour and if so how many in the cell had these mutations
- 5 of them (most common)

23
Q

What happens if you amplify these genes?

A

99% of them dont have the mutations, the PCR products will have the WT base and only 1% will have the mutated base at this position

24
Q

What did they use for sequencing? And what did they use to confirm the sequencing?

A

Used Illiuma to sequence and Sanger to confirm

25
Q

What is an example of an RNA enzyme?

A

ADAR

26
Q

Where is ADAR expressed?

A

It is highly expressed in tumour samples

27
Q

What does ADAR mediate?

A

A –> G edits in target RNA

28
Q

What is highly regulated?

A

RNA editing

29
Q

What did they discover?

A

That performing NGS on tumours is feasible